| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16,275 |
14,219 |
$788K |
| 80053 |
Comprehensive metabolic panel |
64,940 |
50,564 |
$331K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
78,886 |
57,565 |
$224K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
9,841 |
9,071 |
$208K |
| 84443 |
Thyroid stimulating hormone (TSH) |
24,279 |
23,012 |
$197K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,781 |
2,616 |
$108K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
11,370 |
10,567 |
$89K |
| 87088 |
|
16,475 |
14,763 |
$88K |
| 80061 |
Lipid panel |
21,629 |
20,165 |
$80K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
4,704 |
4,524 |
$67K |
| 80306 |
|
10,923 |
9,026 |
$65K |
| 86780 |
|
7,771 |
7,267 |
$64K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,009 |
960 |
$57K |
| 87040 |
|
4,752 |
3,780 |
$52K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,387 |
8,424 |
$51K |
| 82805 |
|
2,250 |
1,351 |
$47K |
| 86003 |
|
1,208 |
1,123 |
$46K |
| 82607 |
|
7,466 |
6,989 |
$44K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
4,214 |
4,038 |
$41K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12,391 |
11,852 |
$39K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,772 |
1,622 |
$38K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,766 |
1,622 |
$38K |
| 84484 |
|
6,830 |
5,446 |
$35K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,053 |
3,925 |
$31K |
| 88307 |
|
543 |
431 |
$30K |
| 83880 |
|
2,709 |
2,326 |
$30K |
| 81001 |
|
21,216 |
18,729 |
$30K |
| 87186 |
|
4,881 |
4,448 |
$29K |
| 82746 |
|
5,053 |
4,660 |
$29K |
| 81025 |
|
11,419 |
10,072 |
$25K |
| 84439 |
|
5,757 |
5,461 |
$25K |
| 83690 |
|
7,163 |
6,305 |
$24K |
| 87070 |
|
6,956 |
6,324 |
$22K |
| 86850 |
|
6,935 |
6,115 |
$20K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
1,408 |
1,373 |
$19K |
| 83970 |
|
1,140 |
1,024 |
$18K |
| 82728 |
|
4,418 |
4,011 |
$18K |
| 86901 |
|
7,980 |
7,048 |
$17K |
| 83550 |
|
3,681 |
3,428 |
$15K |
| 87081 |
|
5,009 |
4,808 |
$14K |
| 85730 |
|
4,211 |
3,033 |
$14K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
322 |
289 |
$14K |
| 86038 |
|
1,812 |
1,731 |
$14K |
| 85027 |
|
4,858 |
4,168 |
$14K |
| 84702 |
|
3,062 |
2,244 |
$13K |
| 86900 |
|
7,812 |
6,898 |
$13K |
| 85610 |
|
6,687 |
4,481 |
$13K |
| 82570 |
|
5,531 |
5,207 |
$13K |
| 82550 |
|
4,281 |
3,460 |
$12K |
| 86225 |
|
2,013 |
1,939 |
$12K |
| 80069 |
|
2,800 |
1,727 |
$12K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
241 |
230 |
$10K |
| 86140 |
|
4,402 |
3,608 |
$10K |
| 80164 |
|
2,209 |
1,320 |
$10K |
| 85379 |
|
2,441 |
2,019 |
$9K |
| 86762 |
|
2,041 |
1,901 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,118 |
1,025 |
$8K |
| 80076 |
|
1,873 |
1,768 |
$7K |
| 87340 |
|
1,119 |
1,016 |
$7K |
| 84153 |
|
1,047 |
967 |
$7K |
| 82784 |
|
1,086 |
1,043 |
$6K |
| 80074 |
|
277 |
256 |
$5K |
| 87486 |
|
222 |
212 |
$5K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
265 |
251 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
272 |
247 |
$5K |
| 87493 |
|
217 |
207 |
$5K |
| 84100 |
|
2,017 |
1,245 |
$5K |
| 87280 |
|
596 |
546 |
$4K |
| 84146 |
|
647 |
622 |
$4K |
| 84403 |
|
306 |
297 |
$4K |
| 85652 |
|
2,991 |
2,665 |
$4K |
| 83615 |
|
1,261 |
892 |
$4K |
| 87045 |
|
611 |
595 |
$4K |
| 82150 |
|
1,076 |
994 |
$3K |
| 82950 |
|
1,484 |
1,446 |
$3K |
| 84550 |
|
1,516 |
1,331 |
$3K |
| 86430 |
|
984 |
967 |
$3K |
| 83001 |
|
300 |
289 |
$3K |
| 87631 |
|
78 |
78 |
$3K |
| 87210 |
|
1,044 |
919 |
$2K |
| 83540 |
|
731 |
651 |
$2K |
| 88304 |
|
123 |
119 |
$2K |
| 80202 |
|
289 |
121 |
$2K |
| 88342 |
|
101 |
93 |
$2K |
| 82248 |
|
906 |
743 |
$2K |
| 87324 |
|
242 |
235 |
$2K |
| 81003 |
|
1,471 |
1,411 |
$2K |
| 84156 |
|
1,274 |
1,076 |
$1K |
| 88141 |
|
227 |
211 |
$1K |
| 86880 |
|
564 |
507 |
$1K |
| 84145 |
|
598 |
434 |
$1K |
| 84480 |
|
287 |
281 |
$1K |
| 85045 |
|
905 |
729 |
$1K |
| 80050 |
General health panel |
64 |
63 |
$1K |
| 84165 |
|
205 |
185 |
$1K |
| 82947 |
|
628 |
558 |
$1K |
| 87449 |
|
153 |
147 |
$1K |
| 82247 |
|
519 |
258 |
$1K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
55 |
55 |
$934.04 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
23 |
22 |
$868.82 |
| 82810 |
|
266 |
189 |
$821.29 |
| 82553 |
|
155 |
142 |
$641.75 |
| 82140 |
|
151 |
97 |
$619.49 |
| 0240U |
|
20 |
13 |
$500.00 |
| 80178 |
|
137 |
74 |
$429.01 |
| 83002 |
|
77 |
75 |
$399.34 |
| 87425 |
|
54 |
54 |
$392.75 |
| 85060 |
|
26 |
24 |
$356.82 |
| 82951 |
|
53 |
51 |
$315.52 |
| 85018 |
|
229 |
224 |
$276.13 |
| 89051 |
|
67 |
50 |
$198.61 |
| 84157 |
|
139 |
112 |
$161.58 |
| 82952 |
|
53 |
51 |
$99.32 |
| 82565 |
|
36 |
27 |
$83.88 |
| 84450 |
|
32 |
26 |
$79.05 |
| 84460 |
|
35 |
26 |
$74.64 |
| 84520 |
|
36 |
27 |
$69.48 |
| 87205 |
|
30 |
25 |
$61.25 |
| 89055 |
|
40 |
37 |
$58.11 |
| 87177 |
|
12 |
12 |
$39.60 |
| 83930 |
|
15 |
12 |
$37.30 |
| 86885 |
|
12 |
12 |
$36.60 |
| 87106 |
|
20 |
12 |
$0.00 |